SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-23-028235
Filing Date
2023-06-05
Accepted
2023-06-05 08:00:18
Documents
14
Period of Report
2023-06-03
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc20054007_8k.htm   iXBRL 8-K 27520
2 EXHIBIT 99.1 brhc20054007_ex99-1.htm EX-99.1 29270
6 image001.jpg GRAPHIC 6882
  Complete submission text file 0001140361-23-028235.txt   214374

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA angn-20230603.xsd EX-101.SCH 3859
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE angn-20230603_lab.xml EX-101.LAB 23290
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE angn-20230603_pre.xml EX-101.PRE 16548
8 EXTRACTED XBRL INSTANCE DOCUMENT brhc20054007_8k_htm.xml XML 4225
Mailing Address 451 D STREET, 5TH FLOOR BOSTON MA 02210
Business Address 451 D STREET, 5TH FLOOR BOSTON MA 02210 (857) 209-0050
Elicio Therapeutics, Inc. (Filer) CIK: 0001601485 (see all company filings)

IRS No.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39990 | Film No.: 23991254
SIC: 2834 Pharmaceutical Preparations